SAUS:LSE:LSE-iShares MSCI Australia UCITS (GBX)

ETF | Others |

Last Closing

USD 3774

Change

+8.00 (+0.21)%

Market Cap

USD 0.41B

Volume

329.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R15:LSE SoftBank Group Corp.

+122.01 (+1.57%)

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

+71.00 (+0.93%)

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+4.95 (+0.57%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.06 (+0.46%)

USD 617.54B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.03 (+0.15%)

USD 617.54B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

-7.25 (-0.36%)

USD 348.03B
0QZK:LSE Coca-Cola Co.

+0.70 (+1.15%)

USD 266.08B
0QZO:LSE 0QZO

-1.40 (-1.24%)

USD 258.54B

ETFs Containing SAUS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.45% 32% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.45% 31% F 41% F
Trailing 12 Months  
Capital Gain 3.54% 44% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.54% 41% F 52% F
Trailing 5 Years  
Capital Gain 37.24% 60% D- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.24% 57% F 65% D
Average Annual (5 Year Horizon)  
Capital Gain 6.84% 62% D 66% D+
Dividend Return 6.84% 61% D- 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.77% 54% F 68% D+
Risk Adjusted Return 49.65% 68% D+ 79% B-
Market Capitalization 0.41B 67% D+ 57% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike